Related references
Note: Only part of the references are listed.Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations
Michael Benzinou et al.
HUMAN MOLECULAR GENETICS (2008)
Abdominal visceral and subcutaneous adipose tissue compartments - Association with metabolic risk factors in the Framingham Heart Study
Caroline S. Fox et al.
CIRCULATION (2007)
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
Magali Gary-Bobo et al.
HEPATOLOGY (2007)
Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men
Paola Russo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population
P. Gazzerro et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites
Dorit P. Jensen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents
Timo Dirk Mueller et al.
MOLECULAR GENETICS AND METABOLISM (2007)
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men
Armand Peeters et al.
ENDOCRINE (2007)
Increasing trends in incidence of overweight and obesity over 5 decades
Nisha I. Parikh et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography
P. Maurovich-Horvat et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Endocannabinoids and the control of energy balance
Isabel Matias et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
Andre J. Scheen et al.
LANCET (2006)
Prevalence of overweight and obesity in the United States, 1999-2004
CL Ogden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
JP Despres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
JC Sipe et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
CB1 cannabinoid receptor-mediated modulation of food intake in mice
JL Wiley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Genomewide linkage analysis of weight change in the Framingham Heart Study
CS Fox et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Endocannabinoid control of food intake and energy balance
V Di Marzo et al.
NATURE NEUROSCIENCE (2005)
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:: 1-year experience from the RIO-Europe study
LF Van Gaal et al.
LANCET (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile
B Poirier et al.
DIABETES OBESITY & METABOLISM (2005)
Genome-wide linkage to chromosome 6 for waist circumference in the Framingham Heart Study
CS Fox et al.
DIABETES (2004)
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
CR Trillou et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Prevention conference VII -: Obesity, a worldwide epidemic related to heart disease and stroke -: Group I:: Worldwide demographics of obesity
DA York et al.
CIRCULATION (2004)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study
LD Atwood et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Share Paper
